Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021
04:15pm, Tuesday, 20'th Jul 2021
DUBLIN, July 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close
10 Stocks to Buy That Will Double in the Second Half of 2021
02:08pm, Friday, 16'th Jul 2021
These 10 stocks to buy have strong free cash flow margins and are trading near the S&P 500's year-to-date return. The post 10 Stocks to Buy That Will Double in the Second Half of 2021 appeared first o
Best Medical Marijuana Stock To Buy In 2021? 2 With Long Term Potential Right Now
08:00am, Wednesday, 14'th Jul 2021
Big Pharmaceutical Companies That Are Top Medicinal Cannabis Stocks The post Best Medical Marijuana Stock To Buy In 2021? 2 With Long Term Potential Right Now appeared first on Marijuana Stocks | Cann
Jazz Pharmaceuticals Announces Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Investor Webcast on July 20, 2021
04:15pm, Tuesday, 13'th Jul 2021
DUBLIN, July 13, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Tuesday, July 20, 2021 at 4:30 p.m. ET / 9:30 p.m.
7 Top-Rated Pharmaceutical Companies to Invest In for July
09:15am, Friday, 09'th Jul 2021
Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest I
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
10:31am, Thursday, 01'st Jul 2021
Jazz Pharma (JAZZ) gets FDA approval for Rylaze to treat acute lymphoblastic leukemia or lymphoblastic lymphoma with hypersensitivity to asparaginase.
Jazz's leukemia drug gets approved by the FDA
08:07am, Thursday, 01'st Jul 2021
Shares of Jazz Pharmaceuticals plc gained 3.5% in premarket trading on Thursday, the day after the Food and Drug Administration said it had approved the company's acute lymphocytic leukemia treatment
Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer
06:40am, Thursday, 01'st Jul 2021
The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphom
DUBLIN, June 30, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze ™ (asparaginase erwinia chrysanthemi (
Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys
07:02am, Tuesday, 29'th Jun 2021
They are great options whether you are investing for the short or long term.
U.S. Food and Drug Administration published its summary of clinical superiority findings for Xywav for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older w
Where Jazz Pharmaceuticals Stands With Analysts
11:50am, Tuesday, 22'nd Jun 2021
Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1 1 Somewhat Bullish 1 1 0 0 Indi
New Strong Sell Stocks for June 22nd
11:16am, Tuesday, 22'nd Jun 2021
ABT, BNL, ITRG, JAZZ, and MANU have been added to the Zacks Rank #5 (Strong Sell) List on June 22, 2021
Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition
08:33am, Thursday, 17'th Jun 2021
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company acquired on May 5. Forecasts total net pr
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc
07:30am, Thursday, 17'th Jun 2021
DUBLIN, June 17, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW) business, which the Compan
